Nkarta Therapeutics

South San Francisco, United States

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

Mar 2024

Post-IPO Equity

Biotechnology Health Care

Top Investors

RA Capital ManagementSamsara BioCapitalJanus Henderson InvestorsNew Enterprise AssociatesOrbiMed

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nkarta Therapeutics

Who are Nkarta Therapeutics's investors?

Nkarta Therapeutics's investors include RA Capital Management, Samsara BioCapital, Janus Henderson Investors, New Enterprise Associates, OrbiMed.

Where is Nkarta Therapeutics headquartered?

Nkarta Therapeutics is headquartered in South San Francisco, United States.

What does Nkarta Therapeutics do?

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

What stage is Nkarta Therapeutics at?

Nkarta Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 25, 2024.

MLA

"Nkarta Therapeutics — Funding & Investors." VCBacked, March 25, 2024, https://www.vcbacked.co/company/nkarta-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Nkarta Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/nkarta-therapeutics

Wikipedia (cite web)

{{cite web |title=Nkarta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nkarta-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 25, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.